Shu-Yung Lin

ministry of environment

H指数:10

被引数:428

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A health outcome-informed vulnerability index and two-stage risk matrix approach to assessing future heat risk in Taiwan

基于健康结果的脆弱性指数和两阶段风险矩阵方法评估台湾未来热风险

International Journal of Disaster Risk Reduction

IF4.5

2026-07-040

OAAI

Epigenetic reprogramming of T cell metabolism restores function and enhances anti-tumor immunity in lung cancer

表观遗传重编程T细胞代谢恢复功能并增强肺癌的抗肿瘤免疫

Nature Immunology

IF27.6

2026-05-120

PRE

A multi-task masked autoencoder with GAN-based augmentation for PD-L1 prediction from chest CT images

基于GAN增广的多任务掩码自编码器用于胸部CT图像的PD-L1预测

Scientific Reports

IF3.9

2026-04-220

OAAI

Clinical Impact of New-Onset Stage II Pressure Injuries in Hospitalised Patients With Multiple Comorbidities

新发Ⅱ期压力性损伤对伴有多种合并症的住院患者的临床影响

Journal of Advanced Nursing

IF3.4

2025-10-280

PRE

Prevalence, clinical reasons and associated factors of extended treatment duration for drug susceptible tuberculosis - a real-world experience

耐多药结核病延长治疗期的患病率、临床原因及相关因素——一项真实世界研究经验

SCIENTIFIC REPORTS

IF3.9

2025-04-270

The prevalence, clinical reasoning and impact of non-standard anti-tuberculosis regimens at the initial prescription

SCIENTIFIC REPORTS

IF3.9

2024-03-071

OAAI

Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities

JOURNAL OF BIOMEDICAL SCIENCE

IF12.1

2023-01-1014

OAAI

The Dynamic Change of Immune Checkpoints and CD14+ Monocytes in Latent Tuberculosis Infection

潜伏性结核感染免疫检查点和CD14单核细胞的动态变化

BIOMEDICINES

IF3.9

2021-10-159

OAAI

Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer

NATURE COMMUNICATIONS

IF15.7

2021-04-1219

OAAI

Completion and Adverse Drug Events of Latent Tuberculosis Infection Treatment in Patients Receiving Dialysis: Predictors and Impacts of Different Regimens in a Prospective Cohort Study

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2021-02-177

Higher adverse drug reactions but better completion rate of twelve-dose weekly rifapentine plus isoniazid comparing with nine-month daily isoniazid for latent tuberculosis infection among patients under maintenance dialysis

EUROPEAN RESPIRATORY JOURNAL

IF21

2020-10-280

PRE

Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma

岩藻糖基转移酶4塑造致癌糖蛋白组驱动肺腺癌转移

EBIOMEDICINE

IF10.8

2020-07-0126

OAAI

Fucosyltransferase 4-mediated aberrant glycosylation and cell signaling networks promote lung cancer metastasis

CANCER RESEARCH

IF16.6

2019-07-011

CONCOMITANT USE OF REPAGLINIDE AND CLOPIDOGREL AND RISK OF HYPOGLYCEMIA: A POPULATION-BASED NESTED CASE-CONTROL STUDY

VALUE IN HEALTH

IF6

2018-09-011

OAAI

Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan

JOURNAL OF CANCER

IF3.2

2018-01-0150

OAAI

Significant Clinical Factors Associated with Long-term Mortality in Critical Cancer Patients Requiring Prolonged Mechanical Ventilation

与需要长期机械通气的危重癌症患者长期死亡率相关的重要临床因素

SCIENTIFIC REPORTS

IF3.9

2017-05-199

OAAI

Shu-Yung Lin

个人简介

教育背景

工作经历

荣誉奖项

研究方向